Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distant and delayed mitomycin C extravasation.

J S Patel1, M Krusa

  • 1Department of Pharmacy, University Medical Center, Jacksonville, Florida, USA.

Pharmacotherapy
|August 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontitis Prediction Model Using Linked Electronic Health and Dental Records.

JDR clinical and translational research·2026
Same author

LinkMD: Linking Medical and Dental Records with 4 Linking Algorithms.

Journal of dental research·2025
Same author

Big Data and Oral Health Disparities: A Critical Appraisal.

Journal of dental research·2024
Same author

Longevity of Crown Margin Repairs Using Glass Ionomer Cement: A Retrospective Study.

Operative dentistry·2021
Same author

A plant biostimulant made from the marine brown algae Ascophyllum nodosum and chitosan reduce Fusarium head blight and mycotoxin contamination in wheat.

PloS one·2019
Same author

First Report of Elm Canker Caused by Pestalotiopsis mangiferae in the United States.

Plant disease·2019
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Mitomycin C, a chemotherapy drug, can cause delayed and distant tissue damage even without immediate signs of extravasation. Healthcare providers and patients must recognize this potential hazard for safer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Dermatology

Background:

  • Mitomycin C is a vesicant chemotherapy agent utilized for solid tumor treatment.
  • Vesicant agents can cause severe tissue damage upon extravasation (leakage from a vein).

Observation:

  • Two cases of delayed and distant mitomycin C extravasation injury were observed.
  • Neither patient showed acute extravasation signs during or immediately after administration.

Findings:

  • One patient experienced erythema, burning, and pain in the contralateral hand within 48 hours.
  • The second patient developed ulcerated lesions on the forearm, proximal to the infusion site, within 6 weeks.

Implications:

  • Mitomycin C can cause unexpected and remote tissue injuries.

Related Experiment Videos

  • Awareness among healthcare professionals and patients is crucial to manage this risk.
  • Further investigation into the mechanisms of delayed mitomycin C extravasation is warranted.